For the year ending 2025-12-31, XRAY has $5,429M in assets. $4,089M in debts. $326M in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 326 | 272 | 334 | 365 |
| Accounts and notes receivable-trade, net | 688 | 556 | 695 | 632 |
| Inventories, net | 642 | 564 | 624 | 627 |
| Prepaid expenses and other current assets | 367 | 354 | 320 | 269 |
| Total current assets | 2,023 | 1,746 | 1,973 | 1,893 |
| Property, plant and equipment, net | 861 | 766 | 800 | 761 |
| Operating lease right-of-use assets, net | 139 | 136 | 178 | 200 |
| Gross carrying amount | 3,007 | - | - | - |
| Accumulated amortization | 2,289 | - | - | - |
| Net carrying amount | 718 | 870 | 1,253 | 1,448 |
| Total indefinite-lived | 256 | 337 | 452 | 455 |
| Identifiable intangible assets, net | 974 | 1,207 | 1,705 | 1,903 |
| Goodwill | - | 2,661 | 2,729 | 6,768 |
| Technologies And Equipment | - | - | - | 4,080 |
| Technologies And Equipment Segment | - | - | 0 | - |
| Consumables Segment | - | - | 0 | 0 |
| Connected Technology Solutions | - | - | 291 | - |
| Essential Dental Solutions | - | - | 0 | - |
| Orthodontic And Implant Solutions | - | - | 0 | - |
| Wellspect Healthcare | - | - | 0 | - |
| Accumulated impairment losses | - | 1,064 | 291 | 4,080 |
| Goodwill, net | 1,148 | 1,597 | 2,438 | 2,688 |
| Other noncurrent assets | 284 | 301 | 276 | 198 |
| Total assets | 5,429 | 5,753 | 7,370 | 7,643 |
| Accounts payable | 300 | 241 | 305 | 279 |
| Accrued liabilities | 700 | 754 | 749 | 727 |
| Income taxes payable | 30 | 45 | 49 | 46 |
| Notes payable and current portion of long-term debt | 313 | 549 | 322 | 118 |
| Total current liabilities | 1,343 | 1,589 | 1,425 | 1,170 |
| Long-term debt | 2,015 | 1,586 | 1,796 | 1,826 |
| Operating lease liabilities | 93 | 91 | 125 | 149 |
| Deferred income taxes | 94 | 129 | 228 | 287 |
| Other noncurrent liabilities | 544 | 415 | 502 | 399 |
| Total liabilities | 4,089 | 3,810 | 4,076 | 3,831 |
| Preferred stock, 1.00 par value 0.25 million shares authorized no shares issued | 0 | 0 | 0 | 0 |
| Common stock, 0.01 par value 400.0 million shares authorized at december31, 2024 and 2023 264.5 million shares issued at december31, 2024 and 2023 198.8 million and 207.2 million shares outstanding at december31, 2024 and 2023, respectively | 3 | 3 | 3 | 3 |
| Capital in excess of par value | 6,644 | 6,640 | 6,643 | 6,629 |
| Accumulated deficit | -1,564 | -835 | 205 | 456 |
| Accumulated other comprehensive loss | -639 | -730 | -636 | -628 |
| Treasury stock, at cost, 64.9 million and 65.7 million shares at december31, 2025 and 2024, respectively | 3,105 | 3,136 | 2,922 | 2,649 |
| Total dentsply sirona equity | 1,339 | 1,942 | 3,293 | 3,811 |
| Noncontrolling interests | 1 | 1 | 1 | 1 |
| Total equity | 1,340 | 1,943 | 3,294 | 3,812 |
| Total liabilities and equity | 5,429 | 5,753 | 7,370 | 7,643 |
DENTSPLY SIRONA Inc. (XRAY)
DENTSPLY SIRONA Inc. (XRAY)